Concord Biotech Share Price Live blog for 10 Oct 2023
Concord Biotech stock price went up today, 10 Oct 2023, by 2.22 %. The stock closed at 1120.35 per share. The stock is currently trading at 1145.2 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news. Concord Biotech Share Price Live blog for 09 Oct 2023
Concord Biotech stock price went up today, 09 Oct 2023, by 2.73 %. The stock closed at 1090.55 per share. The stock is currently trading at 1120.35 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news.
Concord Biotech hits 52-week high after Jefferies initiates 'buy' call; sees 19% upside
Jefferies also prefers Concord Biotech over its peer Glenmark Life Sciences due to its superior growth profile, strong execution track record, industry-leading margins, and favourable return ratios.
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Resignation of Director
Pursuant to Regulation 30 of SEBI LODR, we hereby inform that Mr. Utpal Hemendra Sheth, independent Director of the company has tendered his resignation with effect from 30th September, 2023 citing his personal pre-occupations. he further informed that there are no other material reasons other than those provided in his resignation letter Concord Biotech Share Price Live blog for 26 Sep 2023
Concord Biotech stock price went up today, 26 Sep 2023, by 1.19 %. The stock closed at 983.05 per share. The stock is currently trading at 994.7 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news.
Concord Biotech's niche strengths seen buoying earnings: Analysts
Shares of the Ahmedabad-based biopharma company, which listed a few weeks ago at a more than 20% premium, have notched another 9% gain since then. The shares topped 1,000 in intraday trade on Friday, before closing nearly 2% higher on the NSE at 983.40. Concord Biotech Ltd - 543960 - Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and as per company''code of conduct for regulating, monitoring and reporting of trading by insiders, the trading window for trading in the equity shares of the company will be closed from October 01, 2023 till the expiry of 48 hours after the declaration of the financial results for the Quarter and half year ended september 30, 2023. Accordingly, all designated persons of the company and their immediate relatives have been advised not to trade in the securities of the company during the aforesaid closure of trading window period.
Concord Biotech stock gains 3% as Kotak and Antique Broking issue positive coverage
Kotak Institutional Equities based on strong discounted cash flows and the company's expertise in high entry barrier fermentation active pharmaceutical ingredients (API) segment sees a 15 percent upside potential from the current price levels. Concord Biotech Share Price Live blog for 14 Sep 2023
Concord Biotech stock price went up today, 14 Sep 2023, by 1.82 %. The stock closed at 1004.7 per share. The stock is currently trading at 1023 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news. Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
In continuation of our letter dated September 07, 2023 regarding audio recording of Q1FY 24 earning call for investor and anaysts and pursuant to regulation 30(6) of SEBI LODR, Please find enclosed transcripts of Q1 FY 24 earning call for the Quarter ended on June 30, 2023